Safety Evaluation of Propofol Sedation for Magnetic Resonance Imaging in Pediatric Patients

NCT04455776 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2020-08-26

No results posted yet for this study

Summary

Propofol is often used for sedation in children undergoing magnetic resonance imaging. The investigators will perform a chart review of 4 month of activity (about 100 cases) and review the incidence and severity of adverse events of this sedation technique.

Conditions

  • Multiparametric Magnetic Resonance Imaging
  • Propofol Adverse Reaction
  • Sedation Complication
  • Anesthesia; Adverse Effect

Interventions

DRUG

Propofol

Sedation by propofol

Sponsors & Collaborators

  • Brugmann University Hospital

    lead OTHER

Principal Investigators

  • Denis Schmartz, MD · CHU Brugmann

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-03
Primary Completion
2020-07-30
Completion
2020-07-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04455776 on ClinicalTrials.gov